Nicolas Lebègue

8PUBLICATIONS
24CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsMolecular targetsMolecular medicinePredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 29, 2024
Novel Quinazoline Derivatives as Highly Effective A2A Adenosine Receptor Antagonists.

Amélie Laversin, Robin Dufossez, Raphaël Bolteau

|Dec 23, 2023
Jacalin-Curcumin Complex Sensitizes the Breast Cancer MDA-MB-231 Cell Line.

Lidiya Petrova, Nikolay Gergov, Marie Stoup

|May 28, 2022
Antimicrobial Properties of Compounds Isolated from Syzygium malaccense (L.) Merr. and L.M. Perry and Medicinal Plants Used in French Polynesia.

Camille Quenon, Thierry Hennebelle, Jean-François Butaud

|Mar 25, 2022
A Phosphosite Mutant Approach on LRRK2 Links Phosphorylation and Dephosphorylation to Protective and Deleterious Markers, Respectively.

Antoine Marchand, Alessia Sarchione, Panagiotis S Athanasopoulos

|Nov 27, 2021
The EGF Domains of MUC4 Oncomucin Mediate HER2 Binding Affinity and Promote Pancreatic Cancer Cell Tumorigenesis.

Nicolas Stoup, Maxime Liberelle, Céline Schulz

|Apr 15, 2020
Publisher Correction: MUC4-ErbB2 Oncogenic Complex: Binding studies using Microscale Thermophoresis.

Maxime Liberelle, Romain Magnez, Xavier Thuru

Pageof 2

Frequent Collaborators

2 joint publications

Romain Magnez

2 joint publications

Xavier Thuru

2 joint publications

Patricia Melnyk

1 joint publications

Maxime Liberelle